Could melatonin be used in COVID‐19 patients with laryngopharyngeal reflux disease?

Chia Siang Kow, Syed Shahzad Hasan

Research output: Contribution to journalLetter

Abstract

The study by Jiang et al. [1] to determine the impact of laryngopharyngeal reflux disease (LPRD) on the clinical outcomes in hospitalized patients with novel coronavirus disease 2019 (COVID‐19) is first of its kind study in the literature. While available studies have mostly focused on the effect of cardiovascular comorbidities, the authors' work raises the concurrent gastrointestinal related issues in patients with COVID‐19.
Original languageEnglish
Number of pages3
JournalJournal of Medical Virology
Early online date10 Jun 2020
DOIs
Publication statusE-pub ahead of print - 10 Jun 2020

Fingerprint Dive into the research topics of 'Could melatonin be used in COVID‐19 patients with laryngopharyngeal reflux disease?'. Together they form a unique fingerprint.

  • Cite this